Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco A Zarbin

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
JAMA Ophthalmology|February 16, 2013
Recombinant T-cell receptor ligands in the treatment of uveitisMarco A Zarbin
Lancet (London, England)|July 18, 2014
A new era in medical therapy for retinal degenerative disease?Alessandro Iannaccone, Marco A Zarbin
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 7, 2021
N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis PigmentosaMarco A Zarbin, Gary Novack
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|August 30, 2022
New Prospects for Retinal Pigment Epithelium TransplantationVamsi K Gullapalli, Marco A Zarbin
Ophthalmology. Retina|May 7, 2019
Anti-Vascular Endothelial Growth Factor Drugs to Reduce Diabetic Retinopathy ProgressionAndrew P Schachat, Marco A Zarbin
Retina (Philadelphia, Pa.)|October 7, 2010
Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternativesMarco A Zarbin, Philip J Rosenfeld
Ophthalmology. Retina|March 8, 2021
Application of Clinical Trial Results to Clinical Practice: Some Reminders and ConsiderationsAndrew P Schachat, Marco A Zarbin
Survey of Ophthalmology|January 15, 2014
Trophic factors in the pathogenesis and therapy for retinal degenerative diseasesAnton M Kolomeyer, Marco A Zarbin
Journal of Vitreoretinal Diseases|November 3, 2023
<i>Klebsiella</i> Endogenous Endophthalmitis During the COVID-19 PandemicNathan Agi, Marco A Zarbin, Neelakshi Bhagat
Mayo Clinic Proceedings|December 3, 2013
Regenerative nanomedicine for vision restorationMarco A Zarbin, Timothy Arlow, Robert Ritch
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
JAMA Ophthalmology|February 16, 2013
Recombinant T-cell receptor ligands in the treatment of uveitisMarco A Zarbin
Lancet (London, England)|July 18, 2014
A new era in medical therapy for retinal degenerative disease?Alessandro Iannaccone, Marco A Zarbin
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 7, 2021
N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis PigmentosaMarco A Zarbin, Gary Novack
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|August 30, 2022
New Prospects for Retinal Pigment Epithelium TransplantationVamsi K Gullapalli, Marco A Zarbin
Ophthalmology. Retina|May 7, 2019
Anti-Vascular Endothelial Growth Factor Drugs to Reduce Diabetic Retinopathy ProgressionAndrew P Schachat, Marco A Zarbin
Retina (Philadelphia, Pa.)|October 7, 2010
Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternativesMarco A Zarbin, Philip J Rosenfeld
Ophthalmology. Retina|March 8, 2021
Application of Clinical Trial Results to Clinical Practice: Some Reminders and ConsiderationsAndrew P Schachat, Marco A Zarbin
Survey of Ophthalmology|January 15, 2014
Trophic factors in the pathogenesis and therapy for retinal degenerative diseasesAnton M Kolomeyer, Marco A Zarbin
Journal of Vitreoretinal Diseases|November 3, 2023
<i>Klebsiella</i> Endogenous Endophthalmitis During the COVID-19 PandemicNathan Agi, Marco A Zarbin, Neelakshi Bhagat
Mayo Clinic Proceedings|December 3, 2013
Regenerative nanomedicine for vision restorationMarco A Zarbin, Timothy Arlow, Robert Ritch
Pageof 16